CT-341

N/A

Report date: 2025/04/24 11:41:03

Base Information

Drug NameCT-341

Drug Alias NameCT-341

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionNectin-4 binders

TargetsNectin-4

Therapy Area/IndicationsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusClinical

Highest Status in ChinaN/A

Originator CompaniesShenzhen Celconta Life Science Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesShenzhen Celconta Life Science Co Ltd

Inactive CompaniesN/A

Active IndicationsBreast Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A